Current landscape for T-cell targeting in autoimmunity and transplantation.
about
The immunogenicity of cells derived from induced pluripotent stem cellsImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsFirst-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejectionBiological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention.Tolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation.Is hypertension an autoimmune disease?Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se.Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2.Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.Developing immunologic tolerance for transplantation at the fetal stage.Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection.Immunosuppressive peptides and their therapeutic applications.Taming inflammation by targeting cytokine signaling: new perspectives in the induction of transplantation tolerance.Lung transplantation: chronic allograft dysfunction and establishing immune tolerance.A yeast chemical genetics approach identifies the compound 3,4,5-trimethoxybenzyl isothiocyanate as a calcineurin inhibitor.Cathepsin S Is Involved in Th17 Differentiation Through the Upregulation of IL-6 by Activating PAR-2 after Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis.Activation of the peroxisome proliferator-activated receptor γ counteracts sepsis-induced T cell cytotoxicity toward alloantigenic target cells.Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patients.Absence of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling protects against collagen-induced arthritis.
P2860
Q27003999-61A7034D-4978-4107-BB17-4DC0BDC30261Q27005267-3B3706E2-418E-4C3F-9861-003FC0BD6003Q30389408-48B84A7A-8779-41C8-B48D-1D1828EB81A8Q33636478-6BD1BBE5-58B0-4F7B-B945-C6245C793045Q33694715-C9C5CE41-395D-41D7-9865-24407FD4B390Q34311505-DB289CBF-E944-4B0C-B83E-E741A9083B4DQ34348211-06854D55-F97C-4679-80EC-EF788950EC03Q35894777-ACDE5CC1-B1F4-42D9-AD3D-66ED2DD3B88DQ36757169-160973C7-A90B-40FE-AA9D-01FD65F17B18Q36821577-F2391696-8DA6-4D74-B9DE-E62CB1721B6DQ37585824-08D36114-99F9-466C-A344-3162F72AD0AAQ37957143-7A0E2FE0-7594-4498-8A97-344E453DB463Q38144256-674935A1-9B4C-4C63-A4C1-96B578290D84Q38170857-F50D9D75-9094-4317-B9DA-60AEBD9F84B7Q38217596-4FA00DEF-9CC4-467B-ADC5-E8373B0D3FB9Q38224758-88F84B86-8D36-4A9D-9635-6337AB5BEF0DQ39038898-20BBD889-7A8C-4F80-AF87-1332FE2F757AQ41024037-EB030987-CB9A-4776-A6AB-3494729A95C5Q41563646-DBE7A0A1-6298-4DEE-B6DC-670319DF6168Q41891387-E6711975-3503-4A7E-9AF9-7AFEA304558CQ41932191-8B3B2EBC-6E62-4897-8B15-DEE2478F241CQ46136869-72DC2905-BD55-4F24-8B5F-C26666D4C77CQ54407225-527766F7-36DD-4950-922F-F35977BBDC28
P2860
Current landscape for T-cell targeting in autoimmunity and transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current landscape for T-cell targeting in autoimmunity and transplantation.
@en
Current landscape for T-cell targeting in autoimmunity and transplantation.
@nl
type
label
Current landscape for T-cell targeting in autoimmunity and transplantation.
@en
Current landscape for T-cell targeting in autoimmunity and transplantation.
@nl
prefLabel
Current landscape for T-cell targeting in autoimmunity and transplantation.
@en
Current landscape for T-cell targeting in autoimmunity and transplantation.
@nl
P2093
P2860
P356
P1433
P1476
Current landscape for T-cell targeting in autoimmunity and transplantation.
@en
P2093
Aaron Martin
Daniel R Getts
Emily M L Chastain
Kathryn Wood
Meghann Teague Getts
Stephen D Miller
Sushma Shankar
P2860
P304
P356
10.2217/IMT.11.61
P577
2011-07-01T00:00:00Z